Follicle Stimulating Hormone
"Follicle Stimulating Hormone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity.
| Descriptor ID |
D005640
|
| MeSH Number(s) |
D06.472.699.322.576.288 D06.472.699.631.525.343.288 D12.644.548.691.525.343.288
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Follicle Stimulating Hormone".
Below are MeSH descriptors whose meaning is more specific than "Follicle Stimulating Hormone".
This graph shows the total number of publications written about "Follicle Stimulating Hormone" by people in this website by year, and whether "Follicle Stimulating Hormone" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Follicle Stimulating Hormone" by people in Profiles.
-
Chin VL, Willliams KM, Donnelley T, Censani M, Conroy R, Lerner S, Oberfield SE, McMahon DJ, Zitsman J, Fennoy I. Long-term follow-up of gonadal dysfunction in morbidly obese adolescent boys after bariatric surgery. J Pediatr Endocrinol Metab. 2018 Nov 27; 31(11):1191-1197.
-
Goldman MB, Thornton KL, Ryley D, Alper MM, Fung JL, Hornstein MD, Reindollar RH. A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T). Fertil Steril. 2014 Jun; 101(6):1574-81.e1-2.
-
Aqeilan RI, Hagan JP, de Bruin A, Rawahneh M, Salah Z, Gaudio E, Siddiqui H, Volinia S, Alder H, Lian JB, Stein GS, Croce CM. Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis. Endocrinology. 2009 Mar; 150(3):1530-5.
-
Wright KP, Guibert J, Weitzen S, Davy C, Fauque P, Olivennes F. Artificial versus stimulated cycles for endometrial preparation prior to frozen-thawed embryo transfer. Reprod Biomed Online. 2006 Sep; 13(3):321-5.
-
Brzyski RG, Grow DR, Sims JA, Seltman HJ. Increase in androgen:estrogen ratio specifically during low-dose follicle-stimulating hormone therapy for polycystic ovary syndrome. Fertil Steril. 1995 Oct; 64(4):693-7.
-
Seibel MM, Kearnan M, Kiessling A. Parameters that predict success for natural cycle in vitro fertilization-embryo transfer. Fertil Steril. 1995 Jun; 63(6):1251-4.
-
Kim JH, Richards CJ, Seibel MM. Proper selection of patients for intermediate-dose pure follicle stimulating hormone. J Reprod Med. 1994 Jan; 39(1):1-5.
-
Saffan DS, Seibel MM. Value of subcutaneous and intravenous pulsatile gonadotropin releasing hormone in polycystic ovary disease. J Reprod Med. 1992 Jun; 37(6):545-51.
-
Seibel MM, Smith D, Dlugi AM, Levesque L. Periovulatory follicular fluid hormone levels in spontaneous human cycles. J Clin Endocrinol Metab. 1989 Jun; 68(6):1073-7.
-
Loy R, Seibel MM. Evaluation and therapy of polycystic ovarian syndrome. Endocrinol Metab Clin North Am. 1988 Dec; 17(4):785-813.